These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10797467)

  • 21. The promise of genomics to identify novel therapeutic targets.
    Orth AP; Batalov S; Perrone M; Chanda SK
    Expert Opin Ther Targets; 2004 Dec; 8(6):587-96. PubMed ID: 15584864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications and limitations of genetically modified mouse models in drug discovery and development.
    Lin JH
    Curr Drug Metab; 2008 Jun; 9(5):419-38. PubMed ID: 18537578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of mouse models for the analysis of human disease.
    Semsarian C
    Curr Protoc Hum Genet; 2002 May; Chapter 15():Unit 15.2. PubMed ID: 18428327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetically modified mice in neuropharmacology.
    Brusa R
    Pharmacol Res; 1999 Jun; 39(6):405-19. PubMed ID: 10373238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Random mutagenesis in the mouse as a tool in drug discovery.
    Russ A; Stumm G; Augustin M; Sedlmeier R; Wattler S; Nehls M
    Drug Discov Today; 2002 Dec; 7(23):1175-83. PubMed ID: 12547018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease.
    Shapiro SD
    Eur Respir J; 2007 Feb; 29(2):375-8. PubMed ID: 17264324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding hypertension through genetic manipulation in mice.
    Cvetkovic B; Sigmund CD
    Kidney Int; 2000 Mar; 57(3):863-74. PubMed ID: 10720939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically engineered mouse models for studying inflammatory bowel disease.
    Mizoguchi A; Takeuchi T; Himuro H; Okada T; Mizoguchi E
    J Pathol; 2016 Jan; 238(2):205-19. PubMed ID: 26387641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in large-scale mouse mutagenesis: from genetics to functional genomics.
    Gondo Y
    Nat Rev Genet; 2008 Oct; 9(10):803-10. PubMed ID: 18781157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse genome database (MGD): new features facilitating a model system.
    Eppig JT; Blake JA; Bult CJ; Kadin JA; Richardson JE;
    Nucleic Acids Res; 2007 Jan; 35(Database issue):D630-7. PubMed ID: 17135206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cre-ativity in the liver: transgenic approaches to targeting hepatic nonparenchymal cells.
    Greenhalgh SN; Conroy KP; Henderson NC
    Hepatology; 2015 Jun; 61(6):2091-9. PubMed ID: 25412828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models and human neuropsychiatric disorders.
    Fisch GS
    Behav Genet; 2007 Jan; 37(1):1-10. PubMed ID: 17047896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse phenogenomics, toolbox for functional annotation of human genome.
    Kim IY; Shin JH; Seong JK
    BMB Rep; 2010 Feb; 43(2):79-90. PubMed ID: 20193125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional gene targeting on the pure C57BL/6 genetic background.
    Mishina M; Sakimura K
    Neurosci Res; 2007 Jun; 58(2):105-12. PubMed ID: 17298852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetically engineered mice and its application to bioindustry].
    Koda T; Togashi Y; Nishimura T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic animal models in biomedical research.
    Houdebine LM
    Methods Mol Biol; 2007; 360():163-202. PubMed ID: 17172731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From mouse to man: understanding heart failure through genetically altered mouse models.
    Chu G; Haghighi K; Kranias EG
    J Card Fail; 2002 Dec; 8(6 Suppl):S432-49. PubMed ID: 12555156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting gene expression to the epidermis of transgenic mice: potential applications to genetic skin disorders.
    Rothnagel JA; Longley MA; Bundman D; Greenhalgh DA; Dominey AM; Roop DR
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):59S-61S. PubMed ID: 16788636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.